Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Larry E Morrison

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
BMC Cancer|February 27, 2014
Identification of FISH biomarkers to detect chromosome abnormalities associated with prostate adenocarcinoma in tumour and field effect environmentYing Zhang, Thomas Perez, Beth Blondin, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 29, 2020
Brightfield multiplex immunohistochemistry with multispectral imagingLarry E Morrison, Mark R Lefever, Lauren J Behman, et al.
BMC Cancer|September 1, 2016
MET and PTEN gene copy numbers and Ki-67 protein expression associate with pathologic complete response in ERBB2-positive breast carcinoma patients treated with neoadjuvant trastuzumab-based therapyBenjamin C Calhoun, Bryce Portier, Zhen Wang, et al.
BMC Cancer|August 18, 2010
Analysis of genetic copy number changes in cervical disease progressionFrank A Policht, Minghao Song, Svetlana Sitailo, et al.
Genes, Chromosomes & Cancer|January 24, 2007
Effects of ERBB2 amplicon size and genomic alterations of chromosomes 1, 3, and 10 on patient response to trastuzumab in metastatic breast cancerLarry E Morrison, Susan S Jewell, Lydia Usha, et al.
The American Journal of Pathology|March 29, 2005
Genomic amplification of the human telomerase gene (TERC) in pap smears predicts the development of cervical cancerKerstin Heselmeyer-Haddad, Kathrin Sommerfeld, Nicole M White, et al.
The Journal of Molecular Diagnostics : JMD|April 23, 2003
Chromosomal abnormalities in non-small cell lung carcinomas and in bronchial epithelia of high-risk smokers detected by multi-target interphase fluorescence in situ hybridizationMaura Santos Romeo, Irina A Sokolova, Larry E Morrison, et al.
The American Journal of Pathology|September 26, 2003
Detection of genomic amplification of the human telomerase gene (TERC) in cytologic specimens as a genetic test for the diagnosis of cervical dysplasiaKerstin Heselmeyer-Haddad, Viktor Janz, Philip E Castle, et al.
The American Journal of Pathology|November 7, 2009
Fluorescence in situ hybridization markers for prediction of cervical lymph node metastasesDarawalee Wangsa, Kerstin Heselmeyer-Haddad, Patricia Ried, et al.
The Journal of Molecular Diagnostics : JMD|April 29, 2006
The development of a fluorescence in situ hybridization assay for the detection of dysplasia and adenocarcinoma in Barrett's esophagusShannon M Brankley, Kenneth K Wang, Aaron R Harwood, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
BMC Cancer|February 27, 2014
Identification of FISH biomarkers to detect chromosome abnormalities associated with prostate adenocarcinoma in tumour and field effect environmentYing Zhang, Thomas Perez, Beth Blondin, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 29, 2020
Brightfield multiplex immunohistochemistry with multispectral imagingLarry E Morrison, Mark R Lefever, Lauren J Behman, et al.
BMC Cancer|September 1, 2016
MET and PTEN gene copy numbers and Ki-67 protein expression associate with pathologic complete response in ERBB2-positive breast carcinoma patients treated with neoadjuvant trastuzumab-based therapyBenjamin C Calhoun, Bryce Portier, Zhen Wang, et al.
BMC Cancer|August 18, 2010
Analysis of genetic copy number changes in cervical disease progressionFrank A Policht, Minghao Song, Svetlana Sitailo, et al.
Genes, Chromosomes & Cancer|January 24, 2007
Effects of ERBB2 amplicon size and genomic alterations of chromosomes 1, 3, and 10 on patient response to trastuzumab in metastatic breast cancerLarry E Morrison, Susan S Jewell, Lydia Usha, et al.
The American Journal of Pathology|March 29, 2005
Genomic amplification of the human telomerase gene (TERC) in pap smears predicts the development of cervical cancerKerstin Heselmeyer-Haddad, Kathrin Sommerfeld, Nicole M White, et al.
The Journal of Molecular Diagnostics : JMD|April 23, 2003
Chromosomal abnormalities in non-small cell lung carcinomas and in bronchial epithelia of high-risk smokers detected by multi-target interphase fluorescence in situ hybridizationMaura Santos Romeo, Irina A Sokolova, Larry E Morrison, et al.
The American Journal of Pathology|September 26, 2003
Detection of genomic amplification of the human telomerase gene (TERC) in cytologic specimens as a genetic test for the diagnosis of cervical dysplasiaKerstin Heselmeyer-Haddad, Viktor Janz, Philip E Castle, et al.
The American Journal of Pathology|November 7, 2009
Fluorescence in situ hybridization markers for prediction of cervical lymph node metastasesDarawalee Wangsa, Kerstin Heselmeyer-Haddad, Patricia Ried, et al.
The Journal of Molecular Diagnostics : JMD|April 29, 2006
The development of a fluorescence in situ hybridization assay for the detection of dysplasia and adenocarcinoma in Barrett's esophagusShannon M Brankley, Kenneth K Wang, Aaron R Harwood, et al.
Pageof 3